The observed higher influence of ETAR rather than ETBR expression on chemotherapy response can be explained in terms of data that ET-1 signalling through ETAR imparts a survival benefit of carcinoma cells by inhibiting chemotherapy induced apoptosis. This evidence concerns the gene EDN1 and carcinoma.